In contrast, during tumour progression, pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and prostaglandins are highly expressed and anti-angiogenic factors such as thrombospondin-1 (TSP1) or endostatin are inhibited (Figure 5) [173]. The gene discussed is VEGFA; the disease is neoplasm.